Rare surfactant‐related variants in familial and sporadic pulmonary fibrosis-Reference-Cited by-同舟云学术

Rare surfactant‐related variants in familial and sporadic pulmonary fibrosis

Published:2022-10-02 Issue:12 Volume:43 Page:2091-2101
ISSN:1059-7794
Container-title:Human Mutation
language:en
Short-container-title:Human Mutation

Author:

Sutton Rachel M.¹²,Bittar Humberto Trejo¹²,Sullivan Daniel I.¹²,Silva Agustin Gil¹²,Bahudhanapati Harinath¹²,Parikh Anishka H.¹²,Zhang Yingze¹²³,Gibson Kevin¹²,McDyer John F.²,Kass Daniel J.¹²,Alder Jonathan K.¹²^ORCID

Affiliation:

1. Dorothy P. and Richard P. Simmons Center for Interstitial Lung Disease University of Pittsburgh Pittsburgh Pennsylvania USA

2. Division of Pulmonary, Allergy and Critical Care Medicine Pittsburgh Pennsylvania USA

3. Department of Human Genetics University of Pittsburgh Pittsburgh Pennsylvania USA

Funder

National Heart, Lung, and Blood Institute

Publisher

Hindawi Limited

Subject

Genetics (clinical),Genetics

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/humu.24476

Reference47 articles.

1. A method and server for predicting damaging missense mutations

2. Short telomeres are a risk factor for idiopathic pulmonary fibrosis

3. Lung transplantation for idiopathic pulmonary fibrosis enriches for individuals with telomere-mediated disease

4. Idiopathic Pulmonary Fibrosis: Diagnosis and Treatment

5. Telomerase Mutations in Families with Idiopathic Pulmonary Fibrosis

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. “Alveolar stem cell exhaustion, fibrosis and bronchiolar proliferation” related entities. A narrative review;Pulmonology;2024-09

2. Genetics and Genomics of Pulmonary Fibrosis: Charting the Molecular Landscape and Shaping Precision Medicine;American Journal of Respiratory and Critical Care Medicine;2024-08-15

4. Cellular therapies for idiopathic pulmonary fibrosis: current progress and future prospects;American Journal of Stem Cells;2024

5. Pulmonary Fibrosis Stakeholder Summit: A Joint National Heart, Lung, and Blood Institute, Three Lakes Foundation, and Pulmonary Fibrosis Foundation Workshop Report;American Journal of Respiratory and Critical Care Medicine;2023-12-19